Render Target: SSR
Render Timestamp: 2024-11-14T22:21:14.554Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-20 06:23:31.641
Product last modified at: 2024-08-30T22:45:08.134Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

PRT-4165 #92443

    Product Information

    Product Usage Information

    PRT-4165 is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 1 mg of powder in 0.43 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at room temperature, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 235.2 g/mol
    Purity >98%
    Molecular Formula C15H9NO2
    CAS 31083-55-3
    Solubility Soluble in DMSO at 25 mg/mL or ethanol at 6 mg/mL.

    Background

    The small-molecule PRT-4165 inhibits the E3 ligase activity of Bmi1/Ring1A (IC50 = 3.9 μM), inhibits ubiquitination of topoisomerase Top2α, and alters Bmi1 localization from nucleolar bodies to more disperse nuclear and cytoplasmic localizations (1). PRT-4165 inhibits both Ring1A and RNF2 (Ring1B), which account for the polycomb-repressive complex 1 (PRC1) E3 ubiquitin ligase activity. PRC1-mediated ubiquitylation of histones plays an important role in DNA repair and gene silencing, and may be relevant in determining cell fate and development of human cancers. Treatment of cells with PRT-4165 inhibited H2A ubiquitylation in cells and at sites of DNA damage, resulting in delayed double-strand break (DSB) repair and impaired response to genotoxic stress (2). PRT-4165 treatment of leukemia cells suppressed cell growth and downregulated NOTCH signaling protein expression (3). PRT-4165 treatment of differentiating human embryonic stem cells promoted neuroectodermal differentiation, indicating that Ring1B regulation could be used to direct stem cells toward an early neuronal fate (4).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.